NCT03675880View on ClinicalTrials.gov

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

February 15, 2019

Study Completion Date

April 30, 2019

Conditions
AMD
Interventions
DRUG

TAB014

TAB014 of 1.25mg(0.05ml)、2.00mg(0.08ml)、2.50mg(0.10ml)

Trial Locations (1)

100032

RECRUITING

Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY